In part 2 of a 3-part series, read about the new recommendations and the dMMR/MSI-H, TMB, and NTRK fusion biomarkers.
Patient-reported outcomes are essential to understand and improve the quality of life of people with MBC. Read more here.
Read about outcomes and endpoints and why they are important in determining a trial’s success.
Do your foods, supplements, or drugs interact with your MBC treatment? Click to learn more.
SEARCH OUR SITE
for past articles or specific information.